GTMB 7 - Gene Therapy & Molecular Biology

Gene Therapy and Molecular Biology Vol 7, page 203Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F,Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova J,Bousso P, Le Deist F, Fischer A (2000) Gene therapy ofhuman severe combined immunodeficiency (SCID)-X1disease. Science 288, 669-672.Cavazzana-Calvo M, Hacein-Bey S, Yates F, De Villartay JP, LeDeist F, Fischer A (2001) Gene therapy of severe combinedimmunodeficiencies. J Gene Med 3, 201-206.Challita PM, Kohn DB (1994) Lack of expression from aretroviral vector after transduction of murine hematopoieticstem cells is associated with methylation in vivo. Proc NatlAcad Sci 91, 2567-2571.Chamberlain JS (2002) Gene therapy of muscular dystrophy.Hum Mol Genet 11, 2355-2362.Chao H, Samulski RJ, Bellinger D, Monahan PE, Nichols T,Walsh CE (1999) Persistent expression of canine factor IX inhemophilia B canines. Gene Ther 6, 1695-1704.Chen HH, Mack LM, Kelly R, Ontell M, Kochanek S, ClemensPR (1997) Persistence in muscle of an adenoviral vector thatlacks all viral genes. Proc Natl Acad Sci 94, 1645-1650.Chen M, Kasahara N, Keene DR, Chan L, Hoeffler WK, FinlayD, Barcova M, Cannon PM, Mazurek C, Woodley DT (2002)Restoration of type VII collagen expression and function indystrophic epidermolysis bullosa. Nat Genet 32, 670-675.Cheng SH, Smith AE (2003) Gene therapy progress andprospects: gene therapy of lysosomal storage disorders. GeneTher 10, 1275-1281.Chinnaiya A, Venkat A, Dawn C, Chee WY, Choo KB, GoleLA, Meng CT (1998) Intraheptatic vein fetal blood sampling:current role in prenatal diagnosis. J Obstet Gynaecol Res24, 239-246.Christensen G, Minamisawa S, Gruber PJ, Wang Y, Chien KR(2000) High-efficiency, long-term cardiac expression offoreign genes in living mouse embryos and neonates.Circulation 101, 178-184.Cole FS, Hamvas A, Nogee LM (2003) Genetic disorders ofneonatal respiratory function. Ped Res 50, 157-162.Cosset FL, Takeuchi Y, Battini JL, Weiss RA, Collins MK(1995) High-titer packaging cells producing recombinantretroviruses resistant to human serum. J Virol 69, 7430-7436.Coutelle C, Douar A-M, Colledge WH, Froster U (1995) Thechallenge of fetal gene therapy. Nat Med 1, 864-866.Coutelle C, Rodeck C (2002) On the scientific and ethical issuesof fetal somatic gene therapy. Gene Ther 9, 670-673.Crawford TO, Pardo CA (1996) The neurobiology of childhoodspinal muscular atrophy. Neurobiol Dis 3, 97-110.Daly TM, Vogler C, Levy B, Haskins ME, Sands MS (1999)Neonatal gene transfer leads to widespread correction ofpathology in a murine model of lysosomal storage disease.Proc Natl Acad Sci 96, 2296-2300.David AL, Cook T, Waddington S, Peebles D, Nivsarkar M,Knapton H, Miah M, Dahse T, Noakes D, Schneider H,Rodeck C, Coutelle C, Themis M (2003a) Ultrasound guidedpercutaneous delivery of adenoviral vectors encoding β-galactosidase and human factor IX genes to early gestationfetal sheep in utero. Hum Gene Ther 14, 353-364.David AL, Peebles DM, Gregory L, Themis M, Cook T, CoutelleC, Rodeck C, (2003b) Percutaneous ultrasound-guidedinjection of the trachea in fetal sheep: a novel technique totarget the fetal airways. Fetal Diagn Ther 18, 385-390.Deconinck N, Ragot T, Marechal G, Perricaudet M, Gillis JM(1996) Functional protection of dystrophic mouse (mdx)muscles after adenovirus-mediated transfer of a dystrophinminigene. Proc Natl Acad Sci 93, 3570-3574.DiDonato CJ, Parks RJ, Kothary R (2003) Development of agene therapy strategy for the restoration of survival motorneuron protein expression: implications for spinal muscularatrophy therapy. Hum Gene Ther 14, 179-188.Douar A-M, Adebakin S, Themis M, Pavirani A, Cook T,Coutelle C (1997) Foetal gene delivery in mice by intraamnioticadministration of retroviral producer cells andadenovirus. Gene Ther 4, 883-890.Douar A-M, Themis M, Sandig V, Friedmann T, Coutelle C(1996) Effect of amniotic fluid on cationic lipid mediatedtransfection and viral infection. Gene Ther 3, 789-796.Dziegielewska KM, Ek J, Habgood MD, Saunders NR (2001)Development of the choroid plexus. Microsc Res Tech 52,5-20.Emery AEH (1993) Duchenne muscular dystrophy. OxfordUniversity Press.Emery AEH (2002) The muscular dystrophies. Lancet 359, 687-695.Engelhardt JF, Schlossberg H, Yankaskas JR, Dudus L (1995)Progenitor cells of the adult human airway involved insubmucosal gland development. Development 121, 2031-2046.Engelhardt JF, Yankaskas JR, Ernst SA, Yang Y, Marino CR,Boucher RC, Cohn JA, Wilson JM (1992) Submucosalglands are the predominant site of CFTR expression in thehuman bronchus. Nat Genet 2, 240-248.Engelstädter M, Buchholz CJ, Bobkova M, Steidl S, Merget-Millitzer H, Willemsen RA, Stitz J, Cichutek K (2001)Targeted gene transfer to lymphocytes using murineleukaemia virus vectors pseudotyped with spleen necrosisvirus envelope proteins. Gene Ther 8, 1202-1206.Flake AW, Roncarolo MG, Puck JM, Almeida-Porada G, EvansMI, Johnson MP, Abella EM, Harrison DD, Zanjani ED(1996) Treatment of X-linked severe combinedimmunodeficiency by in utero transplantation of paternalbone marrow. N Engl J Med 335, 1806-1810.Fletcher JC, Richter G (1996) Human fetal gene therapy: moraland ethical questions. Hum Gene Ther 7, 1605-1614.Fowden AL (1995) Nutrient requirements for normal fetalgrowth and metabolism. In: Hanson MA, Spencer JAD,Rodeck CH (Eds.), Fetus and Neonate: Physiology andClinical Applications: Growth. Cambridge University Press,Cambridge, pp. 31-56.Friedmann T (2003) Gene therapy's new era: a balance ofunequivocal benefit and unequivocal harm. Mol Ther 8, 5-7.Furie B, Limentani SA, Rosenfield CG (1994) A practical guideto the evaluation and treatment of hemophilia. Blood 84, 3-9.Gaillard D, Ruocco S, Lallemand A, Dalemans W, Hinnrasky J,Puchelle E (1994) Immunohistochemical localization ofcystic fibrosis transmembrane conductance regulator inhuman fetal airway and digestive mucosa. Ped Res 36, 137-143.Galan HL, Bennett ML, Tyson RW, Owens G, Ragnault TR,Accurso F, Robbins JC, Schaack J (2002) Inefficienttransduction of sheep in utero after intra-amniotic injectionof retroviral producer cells. Am J Obstet Gynecol 187, 469-474.Gansbacher B, European Society of Gene Therapy (2003) Reportof a second serious adverse event in a clinical trial of genetherapy for X-linked severe combined immune deficiency(X-SCID). Position of the European Society of GeneTherapy (ESGT). J Gene Med 5, 261-262.Geipel A, Berg C, Germer U, Krapp M, Kohl M, Gembruch U(2002) Mucopolysaccharidosis VII (Sly disease) as a causeof increased nuchal translucency and non-immune fetalhydrops: study of a family and technical approach to prenataldiagnosis in early and late pregnancy. Prenat Diagn 22, 493-495.203